Health
EU Medicines Committee Backs Innovent's Sintilimab for Advanced Non-Squamous Lung Cancer
The EMA's human medicines committee gave a positive opinion to Innovent's Zybrivo (sintilimab) with chemotherapy for adults with advanced non-squamous non-small cell lung cancer; a European Commission decision is…

